Article Information
History
- August 25, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Theresa J Hydes, PhD1,2,3,*,#,
- Oliver J Kennedy, PhD4,*,
- Kate Glyn-Owen, MD4,
- Ryan Buchanan, PhD4,6,
- Julie Parkes, PhD4,
- Daniel J Cuthbertson, PhD1,2,3,
- Paul Roderick, MD4,† and
- Christopher D Byrne, PhD5,6,#,†
- 1Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, Faculty of Health & Life Sciences, University of Liverpool
- 2University Hospital Aintree, Liverpool University Hospitals NHS Foundation Trust, Liverpool
- 3Liverpool Centre for Cardiovascular Science, University of Liverpool
- 4School of Primary Care, Population Sciences and Medical Education, University of Southampton
- 5Nutrition and Metabolism, Human Development and Health, Faculty of Medicine, University of Southampton
- 6Southampton National Institute for Health and Care Research, Biomedical Research Centre, University Hospital Southampton
- ↵#Address for correspondence
Theresa J Hydes1 or Christopher D Byrne2; 1Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Clinical Sciences Building (3rd floor) University Hospital Aintree, L9 7AL, theresa.hydes{at}liverpool.ac.uk; 2Southampton National Institute for Health and Care Research Biomedical Research Centre, Southampton Centre for Biomedical Research, Mailpoint 218, Southampton General Hospital, Tremona Road, outhampton, SO16 6YD, c.d.byrne{at}soton.ac.uk
Posted August 25, 2023.
Liver fibrosis assessed using non-invasive markers and genetic polymorphisms (PNPLA3 and TM6SF2) predisposing to liver fibrosis, is associated with hospitalization or death from heart failure: a prospective UK Biobank study
